Prasco is introducing the authorized generic of NuvaRing (etonogestrel/ethinyl estradiol vaginal ring). This is Prasco's ninth authorized generic launch in partnership with Merck, and the 9th women's ...

NuvaRing (etonogestrel/ethinyl estradiol) vaginal ring is a prescription drug that’s used to prevent pregnancy. NuvaRing’s cost may depend on factors such as whether you have health insurance and the ...

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd.(NYSE and TASE: TEVA), today announced the availability of ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from ...

The pharmaceutical company is releasing a generic version of the contraceptive The shares of Teva Pharmaceutical Industries Ltd (NYSE:TEVA) are up 0.4% at $11.54 this morning, after the company ...

Shares of Amneal Pharmaceuticals jumped 33% in premarket trading after the generic drugmaker said Thursday that it has started selling EluRyng, the first generic version of Merck's birth-control ...

The Food and Drug Administration has granted Mayne Pharma and Mithra Pharmaceuticals approval for Haloette (etonogestrel and ethinyl estradiol) vaginal hormonal contraceptive ring. Haloette ...

The vaginal ring releases on average 0.12mg/day of etonogestrel, a progestin, and 0.015mg/day of ethinyl estradiol, an estrogen. The Food and Drug Administration (FDA) has approved EluRyng ...

Dr. Reddy’s, which has been dealing with repeated manufacturing setbacks from the FDA, is now facing a new regulatory challenge. It has received a complete response letter for two potentially very ...

Like IUDs or birth control implants, vaginal rings offer an alternative to birth control pills for hormone-based pregnancy prevention. These thin plastic rings sit imperceptibly at the base of the ...

The Food and Drug Administration (FDA) has approved Mayne Pharma and Mithra’s abbreviated New Drug Application (ANDA) for Haloette ®, a generic version of Nuvaring ®, for use by females of ...